Table 3.
Clinical characteristics and adipocyte fatty acid binding protein levels of the 70 kidney transplantation patients
| Characteristic | Number (%) | A-FABP (ng/ml) | P value | |
|---|---|---|---|---|
| Gender | Male | 37 (52.9) | 32.79 ± 29.78 | 0.049* |
| Female | 33 (47.1) | 47.67 ± 32.17 | ||
| Diabetes | No | 47 (67.1) | 30.32 ± 27.57 | < 0.001* |
| Yes | 23 (32.9) | 59.19 ± 30.94 | ||
| Hypertension | No | 38 (54.3) | 30.27 ± 23.05 | 0.005* |
| Yes | 32 (45.7) | 51.14 ± 36.67 | ||
| Transplantation model | Cadaveric | 62 (88.6) | 37.85 ± 31.34 | 0.150 |
| Living | 8 (11.4) | 55.00 ± 31.38 | ||
| Tacrolimus use | No | 29 (41.4) | 43.33 ± 31.12 | 0.436 |
| Yes | 41 (58.6) | 37.31 ± 32.08 | ||
| Mycophenolate mofetil or Myfortic use | No | 21 (30.0) | 47.99 ± 27.22 | 0.157 |
| Yes | 49 (70.0) | 36.30 ± 32.94 | ||
| Steroid use | No | 13 (18.6) | 26.05 ± 20.63 | 0.082 |
| Yes | 57 (81.4) | 42.95 ± 32.94 | ||
| Rapamycin use | No | 56 (80.0) | 36.16 ± 31.75 | 0.388 |
| Yes | 14 (20.0) | 40.38 ± 31.24 | ||
| Cyclosporine use | No | 54 (77.1) | 39.78 ± 32.06 | 0.990 |
| Yes | 16 (22.9) | 39.89 ± 31.02 | ||
*
P < 0.05 was considered statistically significant for the Student’s t-test.